Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)

Completed

• Conditions: Hypertension, Pulmonary
• Interventions: Drug: Assigned pulmonary hypertension medication

• Registration Number: NCT02576002
• Lead Sponsor: Bayer

Brief Summary

To describe the prevalence, incidence and current treatment and procedures patterns in a US pediatric population with PAH in MarketScan database during the period 2010-2013

Detailed Description

Not available

Study Timeline

• Study Start: 2015-10
• Study First Submitted: 2015-10-13
• Study First Submitted QC: 2015-10-14
• Study First Posted: 2015-10-15
• Primary Completion: 2016-01
• Study Completion: 2016-01
• Status Verified: 2016-02
• Last Update Submitted: 2016-02-25
• Last Update Posted: 2016-02-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2691

Inclusion Criteria

• All PAH patients who were in the MarketScan database and who were under age 18 at some time during the years 2010 through 2013

Read More

Exclusion Criteria

Not applicable

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Pediatric PAH patients	Assigned pulmonary hypertension medication	US pediatric population with PAH in MarketScan database during the period 2010-2013

Primary Outcome Measures

Name	Time	Method
Incidence rate of PAH (pulmonary arterial hypertension)	Retrospective analysis of three year period
Prevalence rate of PAH	Retrospective analysis of three year period

Secondary Outcome Measures

Name	Time	Method
Prevalence of comorbidities among PAH patients	Retrospective analysis of three year period
Assigned drug treatment for PAH measured using the MarketScan database	Retrospective analysis of three year period	Description of pulmonary hypertension-targeted drugs prescribed in the study population and changes during the study period
Diagnostic procedures performed among PAH patients measured using the MarketScan database	Retrospective analysis of three year period